Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Brothers Life Sciences Lp
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   28,278,373    

Indirect Shares

   99,473,529      
Direct Value   $957,670,069    

Indirect Value

   $2,829,148,386      
Total Shares   127,751,902      
Total Value   $3,786,818,455      


Synageva BioPharma Corp $0 XOMA Corporation $343,417,787 Genomic Health Inc $576,459,614 Acadia Pharmaceuticals Inc $3,086,280 Incyte Corp $6,857,721 Alexion Pharmaceuticals Inc $24,083,248 Beigene Ltd $3,214,262 Kiniksa Pharmaceuticals, Ltd. $551,158 Synageva BioPharma Corp $0 XOMA Corporation $343,417,787 Genomic Health Inc $576,459,614 Acadia Pharmaceuticals Inc $3,086,280 Incyte Corp $6,857,721 Alexion Pharmaceuticals Inc $24,083,248 Beigene Ltd $3,214,262 Kiniksa Pharmaceuticals, Ltd. $551,158
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    13   
    1    

     Stock price went up :
    13   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   13.0   
   -1.0   
     Percentage Gain/Loss :
   23.7%
 -22.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA Director 2012-07-13 5,077,676 0    Premium*  
            XOMA Corporation XOMA Director 2012-07-19 13,606,093 0    Premium*  
            Genomic Health Inc GHDX Director 2012-07-26 9,086,690 0    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2023-06-01 205,752 2023-06-01 39,330,977    Premium*  
            Seagen Inc SGEN Former 10% Owner, Dire... 2023-12-14 0 2023-12-14 0    Premium*  
            Incyte Corp INCY Director, 10% Owner 2017-09-08 119,681 2017-09-08 822,826    Premium*  
            Aceragen, Inc ACGN Director 0 2014-03-10 1,613,076    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2017-06-15 131,963 2017-06-15 1,074,556    Premium*  
            Beigene Ltd BGNE Director, 10% Owner 2023-11-14 20,838 2023-11-14 9,878,124    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 2021-11-18 0 2021-11-18 7,625,425    Premium*  
            Tscan Therapeutics, Inc. TCRX Director, 10% Owner 2022-05-10 0 2022-05-11 2,528,583    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 2022-06-13 0 2022-06-13 29,190,248    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA Director 2023-06-06 29,680 2023-06-06 2,719,343    Premium*  
            Igm Biosciences, Inc. IGMS Director 2023-06-30 0 2023-09-29 2,896,968    Premium*  
            Madrigal Pharmaceuticals Inc MDGL Director 2023-11-14 0 2023-12-14 1,793,403    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BGNE Beigene Ltd Director   –       •       •   2023-11-14 4 S $180.50 $198,550,000 I/I (1,100,000) 9,691,294 0 %
SGEN Seagen Inc Director   –       •       •   2015-05-11 4 OE $5.11 $102,200 I/I 20,000 26,050,800 0 -
SGEN Seagen Inc Director   –       •       •   2016-03-08 4 OE $4.18 $83,600 I/I 20,000 36,692,540 0 -
INCY Incyte Corp Director   –       •       •   2017-04-27 4 OE $7.26 $435,600 I/I 60,000 787,237 0 -
SGEN Seagen Inc Director   –       •       •   2017-05-15 4 OE $10.20 $204,000 I/I 20,000 40,895,092 0 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2023-01-12 4 OE $5.22 $156,600 I/I 30,000 38,484,981 0 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2023-05-23 4 OE $17.01 $425,250 I/I 25,000 38,620,261 0 -
GEVA Synageva BioPharma Corp Director   –       •      –    2012-07-13 3 IO $0.00 $0 D/D 0 5,077,676 -
XOMA XOMA Corporation Director   –       •      –    2012-07-19 3 IO $0.00 $0 D/D 0 13,606,093 -
GHDX Genomic Health Inc Director   –       •      –    2012-07-26 3 IO $0.00 $0 D/D 0 9,086,690 -
ACAD Acadia Pharmaceuticals In... Director   –       •      –    2013-01-18 3 IO $0.00 $0 D/D 0 14,229,612 -
SGEN Seagen Inc Director   –       •      –    2013-05-17 3 IO $0.00 $0 D/D 0 15,131,223 -
INCY Incyte Corp Director   –       •      –    2013-06-11 3 IO $0.00 $0 D/D 0 12,430,783 -
INCY Incyte Corp Director   –       •      –    2013-06-11 3 IO $0.00 $0 I/I 0 15,000 -
ACGN Aceragen, Inc Director   –       •      –    2014-03-10 3 IO $0.00 $0 I/I 0 1,613,076 -
BGNE Beigene Ltd Director   –       •       •   2017-10-13 4 D $0.00 $0 I/I (49,200) 0 0 -
SGEN Seagen Inc Former 10% Owner   –       •      –    2023-12-14 4 D $229.00 $2,147,483,647 I/I (44,708,503) 0 0 -
SGEN Seagen Inc Former 10% Owner   –       •      –    2023-12-14 4 D $229.00 $10,661,553 D/D (46,557) 0 0 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2013-05-15 4 B $12.50 $24,912,500 I/I 1,993,000 389,909 2.25 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2013-06-03 4 B $14.00 $10,794,615 I/I 767,953 406,609 2.25 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2013-06-04 4 B $14.42 $10,110,693 I/I 699,776 421,826 2.25 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2013-06-05 4 B $14.46 $12,657,999 I/I 872,585 440,802 2.25 -
SGEN Seagen Inc Director   –       •       •   2014-12-15 4 B $31.41 $30,861,290 I/I 973,399 22,083,165 2.25 -
SGEN Seagen Inc Director   –       •       •   2014-12-16 4 B $30.80 $60,997,873 I/I 1,909,979 23,993,144 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-02-24 4 B $33.60 $7,341,491 I/I 217,465 24,210,609 2.25 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us